middle.news
Why Prescient Therapeutics Extended Its $7M Share Purchase Plan
9:26am on Tuesday 15th of July, 2025 AEST
•
Healthcare
Read Story
Why Prescient Therapeutics Extended Its $7M Share Purchase Plan
9:26am on Tuesday 15th of July, 2025 AEST
Key Points
SPP closing date extended to 22 July 2025
Target to raise up to A$7 million from eligible shareholders
Funds directed to Phase 2 development of PTX-100 cancer therapy
Shares offered at 16.7% discount to 15-day VWAP
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Prescient Therapeutics (ASX:PTX)
OPEN ARTICLE